<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font24 { font-size : 24; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font24">and </span>
   <span class="font17">with </span>
   <span class="font17">were </span>
   <span class="font16">EcML </span>
   <span class="font14">that </span>
   <span class="font13">mice </span>
   <span class="font13">for </span>
   <span class="font13">The </span>
   <span class="font13">influenza </span>
   <span class="font13">was </span>
   <span class="font13">vaccine </span>
   <span class="font12">from </span>
   <span class="font12">using </span>
   <span class="font12">MPL </span>
   <span class="font12">after </span>
   <span class="font12">immune </span>
   <span class="font12">immunized </span>
   <span class="font12">levels </span>
   <span class="font11">responses </span>
   <span class="font11">BMDCs </span>
   <span class="font11">&amp;lt; </span>
   <span class="font11">OVA </span>
   <span class="font11">{background </span>
   <span class="font11">cells </span>
   <span class="font11">[]. </span>
   <span class="font11">pHN </span>
   <span class="font11">adjuvant </span>
   <span class="font11">alone </span>
   <span class="font11">cell </span>
   <span class="font11">(Figure </span>
   <span class="font11">margin </span>
   <span class="font11">sera </span>
   <span class="font11">OVA-specific </span>
   <span class="font11">are </span>
   <span class="font11">cellular </span>
   <span class="font11">significantly </span>
   <span class="font11">{border-style </span>
   <span class="font11">antigen </span>
   <span class="font11">immunity </span>
   <span class="font11">increased </span>
   <span class="font11">virus </span>
   <span class="font11">days </span>
   <span class="font11">px;} </span>
   <span class="font11">vaccinated </span>
   <span class="font11">Âµg </span>
   <span class="font11">Î¼g </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">inflammatory </span>
   <span class="font11">than </span>
   <span class="font11">EcMLâ€"OVA </span>
   <span class="font11">efficacy </span>
   <span class="font11">groups </span>
   <span class="font11">humoral </span>
   <span class="font11">measured </span>
   <span class="font10">EcML, </span>
   <span class="font10">IgG </span>
   <span class="font10">against </span>
   <span class="font10">antigen-specific </span>
   <span class="font10">innate </span>
   <span class="font10">observed </span>
   <span class="font10">significant </span>
   <span class="font10">Â°C. </span>
   <span class="font10">Figure </span>
   <span class="font10">IFN-Î³ </span>
   <span class="font10">been </span>
   <span class="font10">enhanced </span>
   <span class="font10">protein </span>
   <span class="font10">stimulated </span>
   <span class="font10">vaccines </span>
   <span class="font10">CD, </span>
   <span class="font10">compared </span>
   <span class="font10">group </span>
   <span class="font10">has </span>
   <span class="font10">results </span>
   <span class="font10">then </span>
   <span class="font10">those </span>
   <span class="font10">Âµg/mL </span>
   <span class="font10">PBS </span>
   <span class="font10">adjuvants </span>
   <span class="font10">alum </span>
   <span class="font10">body </span>
   <span class="font10">cytokine </span>
   <span class="font10">enhancing </span>
   <span class="font10">have </span>
   <span class="font10">including </span>
   <span class="font10">not </span>
   <span class="font10">used </span>
   <span class="font10">TLR </span>
   <span class="font10">activation </span>
   <span class="font10">adaptive </span>
   <span class="font10">data </span>
   <span class="font10">dendritic </span>
   <span class="font10">effects </span>
   <span class="font10">human </span>
   <span class="font10">mice. </span>
   <span class="font10">showed </span>
   <span class="font10">CBL/ </span>
   <span class="font10">between </span>
   <span class="font10">culture </span>
   <span class="font10">enhances </span>
   <span class="font10">higher </span>
   <span class="font10">mixed </span>
   <span class="font10">production </span>
   <span class="font10">shown </span>
   <span class="font10">systemic </span>
   <span class="font10">ELISA. </span>
   <span class="font10">EcMLâ€"vaccine </span>
   <span class="font10">IgGb </span>
   <span class="font10">TNF-Î± </span>
   <span class="font10">determined </span>
   <span class="font10">last </span>
   <span class="font10">level </span>
   <span class="font10">lipid </span>
   <span class="font10">temperature </span>
   <span class="font10">through </span>
   <span class="font10">Î¼g/mL </span>
   <span class="font10">[], </span>
   <span class="font10">can </span>
   <span class="font10">cytokines </span>
   <span class="font10">i.m. </span>
   <span class="font10">independent </span>
   <span class="font10">indicate </span>
   <span class="font10">induces </span>
   <span class="font10">processing </span>
   <span class="font10">protective </span>
   <span class="font10">px; </span>
   <span class="font10">reported </span>
   <span class="font10">responses, </span>
   <span class="font10">serum </span>
   <span class="font10">these </span>
   <span class="font10">three </span>
   <span class="font10">titers </span>
   <span class="font10">titers, </span>
   <span class="font10">treated </span>
   <span class="font10">via </span>
   <span class="font10">{font-family </span>
   <span class="font10">DCs </span>
   <span class="font10">ELISPOT </span>
   <span class="font10">EcML-induced </span>
   <span class="font10">PBS, </span>
   <span class="font10">TLR-defective </span>
   <span class="font10">USA). </span>
   <span class="font10">[,]. </span>
   <span class="font10">also </span>
   <span class="font10">alum, </span>
   <span class="font10">antibody </span>
   <span class="font10">coli </span>
   <span class="font10">either </span>
   <span class="font10">experiments. </span>
   <span class="font10">expression </span>
   <span class="font10">font-size </span>
   <span class="font10">monophosphoryl </span>
   <span class="font10">other </span>
   <span class="font10">previously </span>
   <span class="font10">safety </span>
   <span class="font10">survival </span>
   <span class="font10">this </span>
   <span class="font10">vaccination </span>
   <span class="font10">vitro </span>
   <span class="font10">weight </span>
   <span class="font10">which </span>
   <span class="font10">(C) </span>
   <span class="font10">All </span>
   <span class="font10">B). </span>
   <span class="font10">CA, </span>
   <span class="font10">CH/HeN </span>
   <span class="font10">Collectively, </span>
   <span class="font10">IL- </span>
   <span class="font10">IgG, </span>
   <span class="font10">Immature </span>
   <span class="font10">Mice </span>
   <span class="font10">OVAâ€" </span>
   <span class="font10">SFUs </span>
   <span class="font10">USA) </span>
   <span class="font10">analyzed </span>
   <span class="font10">both </span>
   <span class="font10">but </span>
   <span class="font10">collected </span>
   <span class="font10">combination </span>
   <span class="font10">concentrations </span>
   <span class="font10">differences </span>
   <span class="font10">double; </span>
   <span class="font10">flow </span>
   <span class="font10">groups. </span>
   <span class="font10">improving </span>
   <span class="font10">molecules </span>
   <span class="font10">number </span>
   <span class="font10">obtained </span>
   <span class="font10">pandemic </span>
   <span class="font10">plus </span>
   <span class="font10">protection </span>
   <span class="font10">representative </span>
   <span class="font10">responses. </span>
   <span class="font10">such </span>
   <span class="font10">supernatants </span>
   <span class="font10">treatment </span>
   <span class="font10">use </span>
   <span class="font10">viral </span>
   <span class="font10">when </span>
   <span class="font10">wild-type </span>
   <span class="font10">(A) </span>
   <span class="font10">(B) </span>
   <span class="font10">(BD </span>
   <span class="font10">Abs </span>
   <span class="font10">Additionally, </span>
   <span class="font10">CH/HeJ </span>
   <span class="font10">DQ-OVA </span>
   <span class="font10">EcML-treated </span>
   <span class="font10">EcML. </span>
   <span class="font10">Korea </span>
   <span class="font10">MPL. </span>
   <span class="font10">MPLâ€"vaccine </span>
   <span class="font10">Moreover, </span>
   <span class="font10">NF-ÎºB </span>
   <span class="font10">Research </span>
   <span class="font10">San </span>
   <span class="font10">There </span>
   <span class="font10">Thus, </span>
   <span class="font10">activated </span>
   <span class="font10">addition, </span>
   <span class="font10">adjuvants, </span>
   <span class="font10">alumâ€"vaccine </span>
   <span class="font10">assay. </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">concentration </span>
   <span class="font10">costimulatory </span>
   <span class="font10">cytotoxicity </span>
   <span class="font10">demonstrated </span>
   <span class="font10">difference </span>
   <span class="font10">dilution </span>
   <span class="font10">dose </span>
   <span class="font10">examined </span>
   <span class="font10">group) </span>
   <span class="font10">indicating </span>
   <span class="font10">induction </span>
   <span class="font10">might </span>
   <span class="font10">negative </span>
   <span class="font10">our </span>
   <span class="font10">per </span>
   <span class="font10">previous </span>
   <span class="font10">role </span>
   <span class="font10">signaling </span>
   <span class="font10">solid; </span>
   <span class="font10">specific </span>
   <span class="font10">study, </span>
   <span class="font10">there </span>
   <span class="font10">transient </span>
   <span class="font10">various </span>
   <span class="font10">weeks </span>
   <span class="font10">whether </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(., </span>
   <span class="font10">(Cell </span>
   <span class="font10">(D) </span>
   <span class="font10">(Thermo </span>
   <span class="font10">*** </span>
   <span class="font10">.), </span>
   <span class="font10">Assay </span>
   <span class="font10">C). </span>
   <span class="font10">CTL </span>
   <span class="font10">D). </span>
   <span class="font10">Diego, </span>
   <span class="font10">Enhances </span>
   <span class="font10">Fisher </span>
   <span class="font10">GMT, </span>
   <span class="font10">H.P.; </span>
   <span class="font10">Institute </span>
   <span class="font10">MPL, </span>
   <span class="font10">Our </span>
   <span class="font10">Rev. </span>
   <span class="font10">SFUs, </span>
   <span class="font10">Sera </span>
   <span class="font10">Signaling </span>
   <span class="font10">Splenocytes </span>
   <span class="font10">Statistically </span>
   <span class="font10">While </span>
   <span class="font10">adjuvanted </span>
   <span class="font10">adjuvanticity </span>
   <span class="font10">assay </span>
   <span class="font10">associated </span>
   <span class="font10">bold </span>
   <span class="font10">cause </span>
   <span class="font10">challenged </span>
   <span class="font10">coli-produced </span>
   <span class="font10">could </span>
   <span class="font10">courier; </span>
   <span class="font10">cytometry. </span>
   <span class="font10">cytotoxic </span>
   <span class="font10">described </span>
   <span class="font10">different </span>
   <span class="font10">effective </span>
   <span class="font10">effectively </span>
   <span class="font10">em; </span>
   <span class="font10">engineered </span>
   <span class="font10">enhance </span>
   <span class="font10">enhancement </span>
   <span class="font10">factors </span>
   <span class="font10">followed </span>
   <span class="font10">further </span>
   <span class="font10">generated </span>
   <span class="font10">immunization, </span>
   <span class="font10">immunization. </span>
   <span class="font10">improve </span>
   <span class="font10">improved </span>
   <span class="font10">incubated </span>
   <span class="font10">induce </span>
   <span class="font10">infection </span>
   <span class="font10">infection. </span>
   <span class="font10">infectious </span>
   <span class="font10">influenza-specific </span>
   <span class="font10">investigate </span>
   <span class="font10">its </span>
   <span class="font10">licensed </span>
   <span class="font10">major </span>
   <span class="font10">may </span>
   <span class="font10">mediated </span>
   <span class="font10">min </span>
   <span class="font10">more </span>
   <span class="font10">mouse </span>
   <span class="font10">numbers </span>
   <span class="font10">only </span>
   <span class="font10">pathway </span>
   <span class="font10">pg/mL </span>
   <span class="font10">produced </span>
   <span class="font10">pt;} </span>
   <span class="font10">receptor </span>
   <span class="font10">response </span>
   <span class="font10">resulting </span>
   <span class="font10">revealed </span>
   <span class="font10">robustly </span>
   <span class="font10">safe </span>
   <span class="font10">split </span>
   <span class="font10">strongly </span>
   <span class="font10">studies </span>
   <span class="font10">study </span>
   <span class="font10">suggest </span>
   <span class="font10">vaccination, </span>
   <span class="font10">vaccine. </span>
   <span class="font10">versus </span>
   <span class="font10">viability </span>
   <span class="font10">Â°C </span>
   <span class="font10">Â°C, </span>
   <span class="font10">Âµg/mL) </span>
  </p>
 </body>
</html>
